Detalhe da pesquisa
1.
Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study.
Clin Chem
; 63(7): 1288-1296, 2017 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-28515105
2.
Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib.
Int J Cancer
; 139(10): 2359-69, 2016 11 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27434411
3.
Clinical and molecular implications of MED15 in head and neck squamous cell carcinoma.
Am J Pathol
; 185(4): 1114-22, 2015 04.
Artigo
Inglês
| MEDLINE | ID: mdl-25791637
4.
Implication of the Receptor Tyrosine Kinase AXL in Head and Neck Cancer Progression.
Int J Mol Sci
; 18(1)2016 Dec 22.
Artigo
Inglês
| MEDLINE | ID: mdl-28025482
5.
Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma.
Carcinogenesis
; 35(7): 1636-42, 2014 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-24743512
6.
Fibroblast growth factor receptor 1 amplification is a common event in squamous cell carcinoma of the head and neck.
Mod Pathol
; 26(10): 1298-306, 2013 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-23619603
7.
Transarterial endovascular treatment in the management of life-threatening intra- and postoperative haemorrhages after otorhinolaryngological surgery.
Eur Arch Otorhinolaryngol
; 269(6): 1677-83, 2012 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-22081095
8.
Recurrent HNSCC Harbor an Immunosuppressive Tumor Immune Microenvironment Suggesting Successful Tumor Immune Evasion.
Clin Cancer Res
; 27(2): 632-644, 2021 01 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33109740
9.
PD-L1 (CD274) and PD-L2 (PDCD1LG2) promoter methylation is associated with HPV infection and transcriptional repression in head and neck squamous cell carcinomas.
Oncotarget
; 9(1): 641-650, 2018 Jan 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29416641
10.
Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients.
Clin Epigenetics
; 9: 125, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-29213339
11.
PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma.
Oncotarget
; 8(32): 52889-52900, 2017 Aug 08.
Artigo
Inglês
| MEDLINE | ID: mdl-28881780
12.
PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma.
Clin Epigenetics
; 9: 12, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28174607
13.
MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapy.
Oncotarget
; 8(9): 14719-14735, 2017 Feb 28.
Artigo
Inglês
| MEDLINE | ID: mdl-28146422
14.
PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinoma.
Oncotarget
; 7(46): 75827-75838, 2016 11 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27716615
15.
Evaluation of FGFR3 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
Target Oncol
; 11(5): 631-642, 2016 10.
Artigo
Inglês
| MEDLINE | ID: mdl-27053219
16.
MERTK as a novel therapeutic target in head and neck cancer.
Oncotarget
; 7(22): 32678-94, 2016 May 31.
Artigo
Inglês
| MEDLINE | ID: mdl-27081701
17.
Ectopic Myoglobin Expression Is Associated with a Favourable Outcome in Head and Neck Squamous Cell Carcinoma Patients.
Anticancer Res
; 36(12): 6235-6241, 2016 12.
Artigo
Inglês
| MEDLINE | ID: mdl-27919941
18.
A new bright-field dual-colour chromogenic and silver in situ hybridization method for the detection of FGFR1 gene copy number status.
Virchows Arch
; 464(5): 547-51, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24584974
19.
Fibroblast growth factor receptor-1 as a potential therapeutic target in sinonasal cancer.
Head Neck
; 36(9): 1253-7, 2014 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-23913758
20.
Sex determining region Y-box 2 (SOX2) amplification is an independent indicator of disease recurrence in sinonasal cancer.
PLoS One
; 8(3): e59201, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-23544055